60 DEGREES PHARMACEUTICALS, INC.
Close on Oct 19, 2026
- Market cap
- $2.20M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
60 Degrees Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements 60 Degrees Pharmaceuticals filed with the SEC
60 DEGREES PHARMACEUTICALS, INC. INVESTOR PRESENTATION, DATED OCTOBER 6, 2026
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED OCTOBER 6, 2026
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
60 DEGREES PHARMACEUTICALS, INC. INVESTOR PRESENTATION, DATED SEPTEMBER 8, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 30, 2026
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
60 DEGREES PHARMACEUTICALS, INC. INVESTOR PRESENTATION, DATED JULY 20, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JANUARY 15, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION, DATED JANUARY 8, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
COMPANY INVESTOR PRESENTATION, DATED AS OF SEPTEMBER 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 15, 2025
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 16, 2025
Material agreement · Other events · EX-99.2 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 5, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 6, 2025
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE, DATED JANUARY 29, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JANUARY 30, 2025
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED JANUARY 28, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JANUARY 8, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OCTOBER 3, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 4, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 6, 2024
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
PRESS RELEASE DATED AS OF AUGUST 28, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF AUGUST 12, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF AUGUST 6, 2024
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JULY 25, 2024.
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JULY 9, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JUNE 27, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JUNE 11, 2024.
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF MAY 2, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF MARCH 14, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED AS OF FEBRUARY 20, 2024
Material agreement · Other events · EX-99.1 to Form 8-K
WallachBeth Capital LLC is the Sole Bookrunner for the offering. Sichenzia Ross Ference Carmel LLP is acting as legal counsel to the Company and TroyGould PC, is acting as legal counsel to the underwriters.
Material agreement · Other events · EX-99.1 to Form 8-K
WallachBeth Capital LLC is the Sole Bookrunner for the offering. Sichenzia Ross Ference Carmel LLP is acting as legal counsel to the Company and TroyGould PC, is acting as legal counsel to the underwriters.
Material agreement · Other events · EX-99.2 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF JANUARY 22, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF OCTOBER 12, 2023
Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED SEPTEMBER 18, 2023
Other events · EX-99.1 to Form 8-K
WallachBeth Capital LLC is the Sole Bookrunner for the offering.
Material agreement · Other events · EX-99.1 to Form 8-K
The shares and Tradeable Warrants began trading on the Nasdaq Capital Market on July 12, 2023, under the symbols “SXTP” and “SXTPW,” respectively.
Material agreement · Other events · EX-99.2 to Form 8-K